Literature DB >> 30821068

Managing the need to tell: Triggers and strategic disclosure of thalassemia major in Singapore.

Neha Kumar1, Erin Turbitt1,2, Barbara B Biesecker1, Ilana M Miller1, Breana Cham3, Katherine C Smith4, Rajiv N Rimal4.   

Abstract

This study explored patients' experiences and perceptions of living with thalassemia (an inherited hematologic disorder), perceptions of social stigma, and impact on disclosure decision-making. Semistructured, in-person interviews were conducted in Singapore with 30 individuals: 16 thalassemia major patients and 14 parents of children with thalassemia. Findings were indicative of felt or enacted stigma that may have influenced disclosure decisions. Although affected individuals commonly disclosed their thalassemia diagnosis to family members, they either downplayed the condition with or avoided disclosure to unrelated individuals. Disclosure outside the family occurred only in response to triggers, such as questions about absences due to medical care. Health professionals should provide anticipatory guidance about disclosure strategies when managing individuals with thalassemia. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Southeast Asia; disclosure decision making; genetic condition; stigma; thalassemia major

Mesh:

Year:  2019        PMID: 30821068      PMCID: PMC6467747          DOI: 10.1002/ajmg.a.61107

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  24 in total

1.  'Discovering' chronic illness: using grounded theory.

Authors:  K Charmaz
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

2.  Psychosocial and clinical burden of thalassaemia intermedia and its implications for prenatal diagnosis.

Authors:  S Ratip; D Skuse; J Porter; B Wonke; A Yardumian; B Modell
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

3.  'Rakter dosh'--corrupting blood: The challenges of preventing thalassemia in Bengal, India.

Authors:  Sreeparna Chattopadhyay
Journal:  Soc Sci Med       Date:  2006-08-09       Impact factor: 4.634

Review 4.  The disclosure processes model: understanding disclosure decision making and postdisclosure outcomes among people living with a concealable stigmatized identity.

Authors:  Stephenie R Chaudoir; Jeffrey D Fisher
Journal:  Psychol Bull       Date:  2010-03       Impact factor: 17.737

5.  Thalassemia as a global health problem: recent progress toward its control in the developing countries.

Authors:  D J Weatherall
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

Review 6.  Update on thalassemia: clinical care and complications.

Authors:  Melody J Cunningham
Journal:  Pediatr Clin North Am       Date:  2008-04       Impact factor: 3.278

7.  A model of HIV disclosure: disclosure and types of social relationships.

Authors:  Annette Bairan; Gloria Ann Jones Taylor; Barbara J Blake; Timothy Akers; Richard Sowell; Rick Mendiola
Journal:  J Am Acad Nurse Pract       Date:  2007-05

Review 8.  Management of the thalassemias.

Authors:  Nancy F Olivieri; Gary M Brittenham
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

Review 9.  Thalassemia in SouthEast Asia: problems and strategy for prevention and control.

Authors:  S Fucharoen; P Winichagoon
Journal:  Southeast Asian J Trop Med Public Health       Date:  1992-12       Impact factor: 0.267

10.  Assessing disease disclosure in adults with cystic fibrosis: the Adult Data for Understanding Lifestyle and Transitions (ADULT) survey Disclosure of disease in adults with cystic fibrosis.

Authors:  Avani C Modi; Alexandra L Quittner; Michael P Boyle
Journal:  BMC Pulm Med       Date:  2010-09-10       Impact factor: 3.317

View more
  2 in total

1.  Experience of Uncertainty in Patients with Thalassemia Major: A Qualitative Study.

Authors:  Mehrnaz Ahmadi; Mahin Gheibizadeh; Maryam Rassouli; Abbas Ebadi; Marziyeh Asadizaker; Mojtaba Jahanifar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-10-01

2.  Impact of Primary Immunodeficiency Diseases on the Life Experiences of Patients in Malaysia From the Caregivers' Perspective: A Qualitative Study.

Authors:  Ruwaydah Ahmed Meelad; Intan Juliana Abd Hamid; Ilie Fadzilah Hashim; Zarina Thasneem Zainudeen; Firdaus Farhani Abu Bakar; Fahisham Taib; Norsarwany Mohamad; Ernest Mangantig; Intan Hakimah Ismail; Amir Hamzah Abdul Latiff; Lokman Mohd Noh
Journal:  Front Pediatr       Date:  2022-03-31       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.